<page_title> Tecemotide </page_title> <section_title> Overview and results of all trials </section_title> <table> <cell> NCT00828009 BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery <col_header> Clinical trials: Lung cancer, Breast cancer, Prostate cancer, Colorectal cancer and Multiple myeloma </col_header> <col_header> NCT Number / Title </col_header> </cell> <cell> Biological: bevacizumab, Biological: emepepimut-S, Drug: carboplatin, Drug: cyclophosphamide, Drug: paclitaxel, Radiation: radiation therapy <col_header> Clinical trials: Lung cancer, Breast cancer, Prostate cancer, Colorectal cancer and Multiple myeloma </col_header> <col_header> Interventions </col_header> </cell> </table>
Tecemotide emepepimut-S known as BLP25 is a BLP25 liposome cancer vaccine.